Avior Wealth Management’s CervoMed CRVO Stock Holding History

Avior Wealth Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$4	–	1086
2024 Q4	$4	Hold	2	–	–	﹤0.01%	2456
2024 Q3	$29	Buy	+2	New	+$31	﹤0.01%	2288

Other funds holding CRVO

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

AAS

Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Avior Wealth Management's CRVO Position: Q1 2025 in Review

Avior Wealth Management sold out of CervoMed (CRVO) in Q1 2025, closing a stake of 2 shares — an estimated $4 sold.

Avior Wealth Management first reported a position in CRVO in Q3 2024 and held it in 2 quarters. The position peaked at $29 in Q3 2024. 48 funds tracked by Wall St. Rank hold CRVO as of Q1 2025.

Avior Wealth Management reported no remaining CervoMed position as of Q1 2025 after selling out during the quarter.
Avior Wealth Management sold 2 CervoMed shares in Q1 2025, an estimated $4.
Avior Wealth Management first reported a position in CervoMed in Q3 2024 and held it in 2 quarters.
Avior Wealth Management's CervoMed position peaked at $29 in Q3 2024.
48 funds tracked by Wall St. Rank held CervoMed as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.